US Patent Issued to ONA THERAPEUTICS on June 2 for "Anti-CD36 antibodies and their use to treat cancer" (Spanish Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,954, issued on June 2, was assigned to ONA THERAPEUTICS S.L. (Barcelona, Spain).

"Anti-CD36 antibodies and their use to treat cancer" was invented by Salvador Aznar Benitah (Barcelona, Spain), Merce De Frias Sanchez (Barcelona, Spain), Salvador Guardiola Bagan (Barcelona, Spain), Valerie Vanhooren (Barcelona, Spain) and Beatriz Morancho Armisen (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The claimed invention relates to treating cancer by targeting CD36, a fatty acid receptor. The claimed invention also relates to treating cancer metastases by targeting CD36. The invention involves using anti-CD36 antibodies as blockers or inhibi...